تحمل العبء الأكبر على كبار السن في الدول ذات الدخل 19تأثير جائحة الكوفيد-2020المتدني والمتوسط - رؤى من عام
The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-1...9 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria, and much-needed services for mental health. Combined with a loss of income, many older people are unable to get the medicines they need.
A Summary is available in Russian and Arabic
more
By end of March 2022:
42 COVID-19 detection laboratories were assessed in the 1st Quarter 2022.
23 (55%) Labs are reported fully functional, while 19 (45%) requires assistance to fully operate (i.e., medical supplies, equipment, maintenance, and staffing).
34 (89%) labs have RT-...PCR machines, while 4 (11%) doesn’t have.
Most laboratories operate 1 shift of 8 hours 13 (34%), followed by 2 shifts of 16 hours 11 (29%).
Over 1000 testing capacity per day is reported in Tripoli Biotechnical Centre Lab (5,000), Azzawya NCDC Lab (2,500), Tripoli NCDC public health lab (1500), Misrata NCDC Lab (1,300), and Misrata Medical centre Lab (1,300).
The reported needs ranked per priority are equipment, consumables, and staff training; consequently.
more
Иммунизация является важной медицинской услугой, которая защищает человечество от болезней, предупреждаемых вакцинацией (БПВ)2. Благодаря своевременной имму...низации люди и сообщества обретают защиту, и вероятность вспышки БПВ уменьшается.Предотвращение вспышки БПВ не только спасает жизни, но и требует меньше ресурсовпо сравнению среагированиемна вспышку и помогает снизить нагрузку на систему здравоохранения, и без того перегруженную в результате пандемии COVID-19.
more
Цель настоящего документа заключается в предоставлении конкретных и осуществимых
указаний по выполнению мер для предотвращения, раннего обнаружения и контроля
...COVID-19 в школах и других учебных заведениях. Данное руководство, хотя и было
разработанно для стран, в которых уже подтвердили заражение вирусом COVID-19, также
является актуальным и для других стран. Осведомленность и информированность о
коронавирусе может побудить учащихся стать защитниками профилактики и борьбы с
заболеванием дома, в школах и в своих сообществах путем предотвращения
распространение вируса. Проведении мер предосторожности в школах или открытие школ
после карантина нужно проводить с учетом многих обстоятельств, но если все будет
проделано правильно, это поможет улучшить общественное здравоохранение.
Key messages and actions to prevent and control COVID-19 in schools
more
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th...at the impact of quarantine and testing is likely to vary according to levels of ongoing community transmission, and in the context of ECDC’s current advice that non-essential travel should be avoided during the end-of year festive period
more
The role of community health workers in the vaccination against COVID-19: guide to support the implementation of the vaccination programme
Informationsseite des RKI rund um Impfen und COVID-19
Guidance for General Medical and Specialised Mental Health Care Settings
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
The COVID-19 vaccine introduction toolbox equips all countries to prepare for and implement COVID-19 vaccination by providing guidance, tools, and training. This toolbox is intended to support Ministries of Health, health workers, partner organizations, and other stakeholders.
Accessed: 01.05.2020
El 11 de marzo de 2020 la OMS (Organización Mundial de la salud) ha declarado el CORONAVIRUS - COVID 19 como una pandemia mundial después que el número de afectados fuera de China se haya multiplicado por 13 en dos semanas y el de los demás países se haya triplicado en e...ste mismo periodo
El 26/02/2020 se ha identificado el primer caso de coronavirus en Colombia de una paciente de 19 años proveniente de Milán, Italia y desde la fecha hasta hoy el número de casos se ha multiplicado exponencialmente en el país.
more
Global Level
COVID-19: Vulnerability to containment measures (21/04/2020)
COVID-19: Government Measures: Impact on Displaced Populations (16/04/2020)
COVID-19: Scenarios + Comparison table (10/04/2020)
COVID-19: Government Measures Report (26/03/2020)
Risk communication encompasses all the basics of health communication but differs in the need for speed and reliance on trust. At times of crisis, leaders are called on to provide a quick, sensitive and trustworthy response.
Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
more
Rev Saude Publica. 2022; 56: 22.
Published online 2022 Apr 11. doi: 10.11606/s1518-8787.2022056004040